Other substances

Tivantinib

A c-Met inhibitor.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

Tivantinib is an inhibitor of c-Met signal transduction pathways and therefore has potential antineoplastic activity (NCIt).

Tivantinib on DrugBank
Tivantinib on PubChem
Tivantinib on Wikipedia

 

Structure image - Tivantinib

C1CC2=C3C(=CC=C2)C(=CN3C1)[C@H]4[C@@H](C(=O)NC4=O)C5=CNC6=CC=CC=C65

Supporting references

Link Tested on Impact factor Notes Publication date
Systemic in Silico Screening in Drug Discovery for Coronavirus Disease (COVID-19) with an Online Interactive Web Server
in silico 4.55

Predicted to bind a SARS-CoV-2 protein structural feature.

 Aug/11/2020
Export (.csv)